Ablation of apoptosis-stimulating of p53 protein 1 protects mice from acute hepatic injury and dysfunction via NF-кB pathway in CCl4-induced hepatotoxicity

Tolessa Muleta Daba, Xiang Huang, Timur Yagudin, Ying Yang, Jiangang Wang, Xiaoyu Fu, Yue Zhao, Haiyu Gao, Yang Zhou, Zhenwei Pan, Xiangyu Zhong

PDF(2286 KB)
PDF(2286 KB)
Frigid Zone Medicine ›› 2021, Vol. 1 ›› Issue (1) : 53-64. DOI: 10.2478/fzm-2021-0007
ORIGINAL ARTICLE

Ablation of apoptosis-stimulating of p53 protein 1 protects mice from acute hepatic injury and dysfunction via NF-кB pathway in CCl4-induced hepatotoxicity

Author information +
History +

Abstract

Acute liver injury (ALI) is characterized by apoptosis, inflammation, and oxidative stress, and pathogenic mechanism of ALI is poorly understood. Apoptosis-stimulating of p53 protein 1 (ASPP1) is involved in environmental responses, tumor growth, and NF-KB activity, which is of critical importance to ALI. However, the role of ASPP1 in ALI remains largely unexplored. The current study aimed to determine the role of ASPP1 in ALI induced by CCl4 and the underlying mechanism. ASPP1 expression was detected in wild type (WT) mice with ALI induced by CCl4. The function of ASPP1 in ALI induced by CCl4 was investigated using conventional knockout ASPP1 mice. ASPP1 expression significantly increased in ALI mice at 24 hours after CCl4 injection. Deletion of ASSP1 ameliorated apoptosis, inflammation, and necrosis in ALI relative to WT mice. In addition, deficiency of ASPP1 improved liver flood flow as well as ALT and AST levels. The levels of phosphorylated p65 and phosphorylated IκBα were lower in ASPP1-/- mice than in WT mice with ALI. These results implicate that deletion of ASPP1 may act via inhibition of the NF-кB pathway and protect mice from ALI, which may be a new potential therapeutic target for the treatment of ALI.

Keywords

Apoptosis / ASPP1 / CCl4 / Liver injury / Inflammation / NF-κB

Cite this article

Download citation ▾
Tolessa Muleta Daba, Xiang Huang, Timur Yagudin, Ying Yang, Jiangang Wang, Xiaoyu Fu, Yue Zhao, Haiyu Gao, Yang Zhou, Zhenwei Pan, Xiangyu Zhong. Ablation of apoptosis-stimulating of p53 protein 1 protects mice from acute hepatic injury and dysfunction via NF-кB pathway in CCl4-induced hepatotoxicity. Frigid Zone Medicine, 2021, 1(1): 53‒64 https://doi.org/10.2478/fzm-2021-0007

References

[[1]]
Piñeiro-Carrero V M, Piñeiro E O. Liver. Pediatrics, 2004; 113(4 Suppl): 1097-1106.
[[2]]
Ippolito J A, Curtis B J, Choudhry M A, et al. Alcohol and immunology: Summary of the 2012 Alcohol and Immunology Research Interest Group (AIRIG) meeting. Alcohol (Fayetteville, NY), 2013; 47(8): 589-593.
[[3]]
Shen H, Jiang L, Lin J D, et al. Brown fat activation mitigates alcohol-induced liver steatosis and injury in mice. The Journal of Clinical Investigation, 2019; 129(6):2305-2317.
[[4]]
Yoda T, Crawshaw L I, Saito K, et al. Effects of alcohol on autonomic responses and thermal sensation during cold exposure in humans. Alcohol (Fayetteville, NY), 2008; 42(3): 207-212.
[[5]]
Lopez A M, Hendrickson R G. Toxin-induced hepatic injury. Emergency Medicine Clinics of North America, 2014; 32(1): 103-25.
[[6]]
Alam M F, Safhi M M, Anwer T, et al. Therapeutic potential of Vanillylacetone against CCl(4) induced hepatotoxicity by suppressing the serum marker, oxidative stress, inflammatory cytokines and apoptosis in Swiss albino mice. Experimental And Molecular Pathology, 2018; 105(1):81-88.
[[7]]
Alric L, Orfila C, Carrere N, et al. Reactive oxygen intermediates and eicosanoid production by kupffer cells and infiltrated macrophages in acute and chronic liver injury induced in rats by CCl4. Inflammation Research: Official Journal of The European Histamine Research Society, 2000; 49(12): 700-707.
[[8]]
Sullivan A, Lu X. ASPP: a new family of oncogenes and tumour suppressor genes. British Journal of Cancer, 2007; 96(2): 196-200.
[[9]]
Samuels-Lev Y, O’Connor D J, Bergamaschi D, et al. ASPP proteins specifically stimulate the apoptotic function of p53. Molecular Cell, 2001; 8(4):781-794.
[[10]]
Aylon Y, Ofir-Rosenfeld Y, Yabuta N, et al. The Lats2 tumor suppressor augments p53-mediated apoptosis by promoting the nuclear proapoptotic function of ASPP1. Genes & development, 2010; 24(21): 2420-2429.
[[11]]
Agirre X, Román-Gómez J, Jiménez-Velasco A, et al. ASPP1, a common activator of TP53, is inactivated by aberrant methylation of its promoter in acute lymphoblastic leukemia. Oncogene, 2006; 25(13): 1862-1870.
[[12]]
Xu P, Yao J, Ji J, et al. Deficiency of apoptosis-stimulating protein 2 of p 53 protects mice from acute hepatic injury induced by CCl(4) via autophagy. Toxicology Letters, 2019; 316: 85-93.
[[13]]
Baker R G, Hayden M S, Ghosh S. NF-κB, inflammation, and metabolic disease. Cell Metabolism, 2011; 13(1): 11-22.
[[14]]
Hayden M S, Ghosh S. Shared principles in NF-kappaB signaling. Cell, 2008; 132(3):344-362.
[[15]]
Li B, Li D, Wang Y, et al. Schisantherin A alleviated alcohol-induced liver injury by the regulation of alcohol metabolism and NF-kB pathway. Experimental Animals, 2018; 67(4): 451-461.
[[16]]
Zhang Z, Tian L, Jiang K. Propofol attenuates inflammatory response and apoptosis to protect d-galactosamine/lipopolysaccharide induced acute liver injury via regulating TLR4/NF-κB/NLRP3 pathway. International Immunopharmacology, 2019; 77: 105974.
[[17]]
Li Z, Zhang J, Mulholland M, et al. mTOR activation protects liver from ischemia/reperfusion-induced injury through NF-κB pathway. FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology, 2017; 31(7): 3018-3026.
[[18]]
Luo P, Qin C, Zhu L, et al. Ubiquitin-Specific peptidase 10 (USP10) inhibits hepatic steatosis, insulin resistance, and inflammation through sirt6. Hepatology (Baltimore, Md), 2018; 68(5): 1786-803.
[[19]]
Hua H, Zhang Z, Qian Y, et al. Inhibition of the mitochondrial complex-1 protects against carbon tetrachloride-induced acute liver injury. Biomedicine & Pharmacotherapy= Biomedecine & Pharmacotherapie, 2019; 115: 108948.
[[20]]
Boll M, Weber L W, Becker E, et al. Mechanism of carbon tetrachloride-induced hepatotoxicity. Hepatocellular damage by reactive carbon tetrachloride metabolites. Zeitschrift fur Naturforschung C, Journal of Biosciences, 2001; 56(7-8): 649-659.
[[21]]
Hershko C, Abrahamov A, Konijn AM, et al. Objectives and methods of iron chelation therapy. Bioinorganic Chemistry and Applications, 2003; 1(2): 151-68.
[[22]]
Liu H, Wang Z, Nowicki M J. Caspase-12 mediates carbon tetrachloride-induced hepatocyte apoptosis in mice. World Journal of Gastroenterology, 2014; 20(48): 18189-18198.
[[23]]
Dufour D R, Lott J A, Nolte F S, et al. Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clinical Chemistry, 2000; 46(12): 2050-2068.
[[24]]
Wu L, Zhang Q, Mo W, et al. Quercetin prevents hepatic fibrosis by inhibiting hepatic stellate cell activation and reducing autophagy via the TGF-β1/Smads and PI3K/Akt pathways. Scientific Reports, 2017; 7(1): 9289.
[[25]]
Feng J, Wang C, Liu T, et al. Procyanidin B2 inhibits the activation of hepatic stellate cells and angiogenesis via the Hedgehog pathway during liver fibrosis, 2019; 23(9): 6479-6493.
[[26]]
Takahashi H, Shigefuku R, Yoshida Y, et al. Correlation between hepatic blood flow and liver function in alcoholic liver cirrhosis. World Journal of Gastroenterology, 2014; 20(45): 17065-17074.
[[27]]
Van der Graaff D, Kwanten W J, Francque S M. The potential role of vascular alterations and subsequent impaired liver blood flow and hepatic hypoxia in the pathophysiology of non-alcoholic steatohepatitis. Medical Hypotheses, 2019; 122: 188-197.
[[28]]
Zhao J, Wu G, Bu F, et al. Epigenetic silence of ankyrin-repeat-containing, SH3-domain-containing, and proline-rich-region- containing protein 1 (ASPP1) and ASPP2 genes promotes tumor growth in hepatitis B virus-positive hepatocellular carcinoma. Hepatology (Baltimore, Md), 2010; 51(1): 142-153.
[[29]]
Liu H, Chen F, Zhang L, et al. A novel all-trans retinoic acid derivative 4-amino-2-trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP. Oncology Reports, 2016; 36(1): 333-341.
[[30]]
Zhao K, Yu M, Zhu Y, et al. EGR-1/ASPP 1 inter-regulatory loop promotes apoptosis by inhibiting cyto-protective autophagy. Cell Death & Disease, 2017; 8(6): e2869.
[[31]]
Rasool F, Nayak D, Katoch A, et al. Regiospecific synthesis of ring a fused withaferin a isoxazoline analogues: induction of premature senescence by W-2b in proliferating cancer cells. Scientific Reports, 2017; 7(1):13749.
[[32]]
Chen L, Li S, Guo X, et al. The role of GSH in microcystin-induced apoptosis in rat liver: Involvement of oxidative stress and NF-κB. Environmental toxicology, 2016; 31(5):552-560.
[[33]]
Zhao X, Jiang K, Liang B, et al. Anticancer effect of xanthohumol induces growth inhibition and apoptosis of human liver cancer through NF-κB/p53- apoptosis signaling pathway. Oncology Reports, 2016; 35(2):669-675.
[[34]]
Chen X, Zhang J, Yi R, et al. Hepatoprotective effects of lactobacillus on carbon tetrachloride-induced acute liver injury in mice. International Journal of Molecular Sciences, 2018; 19(8).
[[35]]
Qi B, Zhang S, Guo D, et al. Protective effect and mechanism of ginsenoside Rg 1 on carbon tetrachloride-induced acute liver injury. Molecular Medicine Reports, 2017; 16(3):2814-22.
[[36]]
Benyamini H, Friedler A. The ASPP interaction network: electrostatic differentiation between pro- and anti-apoptotic proteins. Journal of molecular recognition: JMR, 2011; 24(2): 266-274.
[[37]]
Feldman A T, Wolfe D. Tissue processing and hematoxylin and eosin staining. Methods in Molecular biology (Clifton, NJ), 2014; 1180:31-43.
[[38]]
Slaoui M, Bauchet A L, Fiette L. Tissue sampling and processing for histopathology evaluation. Methods in Molecular Biology (Clifton, NJ), 2017; 1641: 101-114.
[[39]]
Camargo C A Jr., Madden J F, Gao W, et al. Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology (Baltimore, Md), 1997 ; 26(6): 1513- 1520.
[[40]]
Chen W B, Lai S S, Yu D C, et al. GGPPS deficiency aggravates CCl4- induced liver injury by inducing hepatocyte apoptosis. Febs Letters, 2015; 589(10): 1119-1126.
PDF(2286 KB)

Accesses

Citations

Detail

Sections
Recommended

/